Bristol-Myers: Analysis On Celgene Deal - Seeking Alpha
 

Bristol-Myers: Analysis On Celgene Deal Seeking AlphaBristol-Myers announced a $90 billion deal for Celgene, roughly equal to its own valuation. The deal is not really welcomed by investors, which shun ...
View full coverage on Google News

More...